https://dhvi.duke.edu/profile/laura-pope-hale
Laura Pope Hale | Duke Human Vaccine Institute
human vaccinelaurapopehaleduke
https://dhvi.duke.edu/programs-and-centers/shared-resources/cores
Cores | Duke Human Vaccine Institute
human vaccinecoresdukeinstitute
https://dhvi.duke.edu/profile/andrew-neil-macintyre
Andrew Neil Macintyre | Duke Human Vaccine Institute
andrew neilhuman vaccinemacintyredukeinstitute
https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/flowjo-licenses
FlowJo Licenses | Duke Human Vaccine Institute
human vaccineflowjolicensesdukeinstitute
https://dhvi.duke.edu/personnel/marek-poniewierski
Marek Poniewierski | Duke Human Vaccine Institute
human vaccinemarekdukeinstitute
https://dhvi.duke.edu/
Duke Human Vaccine Institute
human vaccinedukeinstitute
https://dhvi.duke.edu/personnel/darin-weed
Darin Weed | Duke Human Vaccine Institute
Training B.S., Biotechnology, Minnesota State University Ph.D., Immunology and Infectious Disease, Washington State University Postdoctoral, University of...
human vaccinedarinweeddukeinstitute
https://dhvi.duke.edu/personnel/georgia-tomaras-phd
Georgia Tomaras, PhD | Duke Human Vaccine Institute
human vaccinegeorgiaphddukeinstitute
https://dhvi.duke.edu/programs-and-centers/chavd/chavd-annual
CHAVD Annual Retreats | Duke Human Vaccine Institute
annual retreatshuman vaccinedukeinstitute
https://dhvi.duke.edu/profile/matthew-kelly
Matthew Kelly | Duke Human Vaccine Institute
matthew kellyhuman vaccinedukeinstitute
https://dhvi.duke.edu/personnel/salvatore-scianna
Salvatore Scianna | Duke Human Vaccine Institute
Salvatore Scianna has worked on the NIAID/DAIDS Virology Quality Assurance Program for over 25 years. Sal oversees the production, validation, and distribution...
human vaccinesalvatoresciannadukeinstitute
https://dhvi.duke.edu/programs-and-centers/collaborative-influenza-vaccine-innovation-centers/clinical-core/accessioning
Accessioning Unit & Biorepository | Duke Human Vaccine Institute
The team provides support for the recruiting participants of all ages as well as processing,
human vaccineaccessioningunitbiorepositoryduke
https://dhvi.duke.edu/programs-and-centers/immunology-virology-quality-assessment-center/research-programs/virology-2
Virology Quality Assurance Program (VQA) | Duke Human Vaccine Institute
quality assurance programhuman vaccinevirologyvqaduke
https://dhvi.duke.edu/personnel/darren-morrow
Darren Morrow | Duke Human Vaccine Institute
human vaccinedarrenmorrowdukeinstitute
https://dhvi.duke.edu/cain-lab
Cain Lab | Duke Human Vaccine Institute
human vaccinecainlabdukeinstitute
https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/technical-help
Technical Help | Duke Human Vaccine Institute
technical helphuman vaccinedukeinstitute
https://dhvi.duke.edu/saunders-lab
Saunders Lab | Duke Human Vaccine Institute
human vaccinesaunderslabdukeinstitute
https://dhvi.duke.edu/personnel/monica-johnson
Monica Johnson | Duke Human Vaccine Institute
human vaccinemonicajohnsondukeinstitute
https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/policies-and-faqs
Policies and FAQs | Duke Human Vaccine Institute
policies and faqshuman vaccinedukeinstitute
https://dhvi.duke.edu/personnel/olivia-williams
Olivia Williams | Duke Human Vaccine Institute
olivia williamshuman vaccinedukeinstitute
https://dhvi.duke.edu/programs-and-centers/duke-center-hiv-structural-biology/publications
Publications | Duke Human Vaccine Institute
Peer-reveiwed Papers Liu Q, Parsons RJ, Wiehe K, Edwards RJ, Saunders KO, Zhang P, Miao H, Tilahun K, Jones J, Chen Y, Hora B, Williams WB, Easterhoff D, Huang...
human vaccinepublicationsdukeinstitute
https://dhvi.duke.edu/about-us/training-and-mentoring-program/people/postdocs-and-other-associates
Postdocs and Other Associates | Duke Human Vaccine Institute
and otherhuman vaccinepostdocsassociatesduke
https://dhvi.duke.edu/profile/christopher-wildrick-woods
Christopher Wildrick Woods | Duke Human Vaccine Institute
human vaccinechristopherwoodsdukeinstitute
https://dhvi.duke.edu/programs-and-centers/duke-center-hiv-structural-biology/investigators
Investigators | Duke Human Vaccine Institute
human vaccineinvestigatorsdukeinstitute
https://dhvi.duke.edu/programs-and-centers/immunology-virology-quality-assessment-center/research-programs/external
Leadership at EQAPOL | Duke Human Vaccine Institute
human vaccineleadershipdukeinstitute
https://dhvi.duke.edu/publications
Publications | Duke Human Vaccine Institute
human vaccinepublicationsdukeinstitute
https://dhvi.duke.edu/personnel/lori-hendrickson
Lori Hendrickson | Duke Human Vaccine Institute
human vaccinelorihendricksondukeinstitute
https://dhvi.duke.edu/diseases/syphilis
Syphilis | Duke Human Vaccine Institute
Syphilis during pregnancy can result in miscarriage and fetal loss, or can result in congenital syphilis, an infection that causes organ damage and life-long...
human vaccinesyphilisdukeinstitute
https://dhvi.duke.edu/programs-and-centers/chavd/research-support-teams
Research Support Teams | Duke Human Vaccine Institute
The Duke CHAVD Scientific Research Support Units (SRSUs) form a well-coordinated translational pathway led by outstanding investigators that excel at...
research support teamshuman vaccinedukeinstitute
https://dhvi.duke.edu/programs-and-centers/chavd/news-and-events
News | Duke Human Vaccine Institute
human vaccinenewsdukeinstitute
https://dhvi.duke.edu/about-us/giving
Giving | Duke Human Vaccine Institute
At the Duke Human Vaccine Institute, we believe in the extraordinary impact of generosity.
human vaccinegivingdukeinstitute
https://dhvi.duke.edu/personnel/damani-hillman-ccrp
D'Amani Hillman, CCRP | Duke Human Vaccine Institute
human vaccineamanihillmanccrpduke
https://dhvi.duke.edu/personnel/raul-louzao
Raul Louzao | Duke Human Vaccine Institute
Mr. Louzao is the Scientific Manager of the Immunology and Virology Quality Assurance Laboratory (IVQAC) which serves as the EQAPOL Central Laboratory. For the...
human vaccinerauldukeinstitute
https://dhvi.duke.edu/personnel/garry-juhans
Garry Juhans | Duke Human Vaccine Institute
human vaccinegarrydukeinstitute
https://dhvi.duke.edu/profile/herman-ford-staats
Herman Ford Staats | Duke Human Vaccine Institute
human vaccinehermanfordstaatsduke
https://dhvi.duke.edu/profile/kent-james-weinhold
Kent James Weinhold | Duke Human Vaccine Institute
human vaccinekentjamesdukeinstitute
https://dhvi.duke.edu/programs-and-centers/pandemic-preparedness/duke-infectious-disease-response-training-didrt-0
Resources and Links for Pandemic Preparedness Programs | Duke Human Vaccine Institute
NIEHS National Clearinghouse for Worker Safety and Health Training NIEHS Worker Training Program CDC COVID-19 Page CDC Ebola Virus Page CDC Severe Acute...
resources and linkspandemic preparednesshuman vaccine
https://dhvi.duke.edu/profile/robert-joseph-rolfe
Robert Joseph Rolfe | Duke Human Vaccine Institute
human vaccinerobertjosephrolfeduke
https://pubmed.ncbi.nlm.nih.gov/38854753/?dopt=Abstract
Estimated Human Papillomavirus Vaccine Coverage Among Females 9-45 Years of Age - China, 2017-2022
This study presents evidence of low HPV vaccine coverage when administered outside of a national immunization program. Therefore, it is recommended that the...
https://www.livescience.com/early-hiv-vaccine-trial-results.html
HIV vaccine stimulates 'rare immune cells' in early human trials | Live Science
Apr 7, 2021 - The vaccine stimulated a set of one-in-a-million immune cells.
immune cells
https://www.techtransfer.nih.gov/patent/e-122-1988-0-il-16
GENE FOR ENCODING A HUMAN MALARIA VACCINE ANTIGEN | Technology Transfer
malaria vaccinegeneencodinghumanantigen
https://pmc.ncbi.nlm.nih.gov/articles/PMC6361347/
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women - PMC
Over an 11-year period after HPV vaccine introduction, we found in this community-based surveillance study evidence of vaccine effectiveness and herd...
human papillomavirus vaccineyoung womeneffectiveness
https://www.mdpi.com/2076-393X/8/1/117
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in...
Vaccine safety surveillance is essential in vaccination programs. We accomplished a descriptive study of surveillance AEFI-reporting rate in human...
human papillomavirus vaccineadverse events
https://health.economictimes.indiatimes.com/news/industry/bangladeshs-1st-homegrown-covid-19-vaccine-gets-clearance-for-human-trials/92956734
Bangavax: Bangladesh's 1st homegrown COVID-19 vaccine gets clearance for human trials, ETHealthworld
Bangavax: The vaccine can reportedly be stored at a temperature of 4 degrees Celsius for one month and of minus 20 degrees Celsius for up to six months.
https://scholars.lib.ntu.edu.tw/entities/publication/998b65cc-a587-4edc-b9b8-a0b4f8bb923e
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants
https://kidshealth.org/BarbaraBushChildrens/en/parents/hpv-vaccine.html
Your Child's Vaccines: Human Papillomavirus (HPV) Vaccine (for Parents) - Barbara Bush Children's...
Find out when and why your child needs to get this vaccine.
human papillomavirus hpv
https://economictimes.indiatimes.com/news/politics-and-nation/human-clinical-trials-for-covid-19-vaccine-initiated-in-india-icmr/articleshow/76964826.cms
Human trials for COVID-19 vaccine initiated in India, with 1,000 volunteers: ICMR - The Economic...
The Drugs Controller General of India (DCGI) has permitted two vaccines -- one developed by Bharat Biotech International Limited in collaboration with the...
https://pubmed.ncbi.nlm.nih.gov/20179231/
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and...
Vaccination with mutationally inactivated, nononcogenic Ad-HER2-ki results in robust polyclonal immune responses to HER2 in tolerant models, which translates...
https://pmc.ncbi.nlm.nih.gov/articles/PMC302470/
Protective Study with a Group A Streptococcal M Protein Vaccine. INFECTIVITY CHALLENGE OF HUMAN...
Healthy adult male volunteers were immunized with purified M protein from Group A streptococci. Type 1. The vaccine was administered subcutaneously as an...
https://www.jpost.com/health-science/singapore-scientists-to-start-covid-19-vaccine-human-trials-in-august-631648
Singapore scientists to start COVID-19 vaccine human trials in August | The Jerusalem Post
More than 100 vaccines are being developed globally, including several already in human trials from the likes of AstraZeneca and Pfizer.
https://researchconnect.buffalo.edu/en/publications/acceptability-of-the-human-papillomavirus-vaccine-among-diverse-h/
Acceptability of the human papillomavirus vaccine among diverse hispanic mothers and grandmothers -...
human papillomavirus vaccineof the
https://www.techtransfer.nih.gov/patent/e-297-2016-2-au-11
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES |...
respiratory syncytial virusvaccine candidatesfor human